FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to pharmaceutical industry, namely to an immunostimulant for enhancing the immune response. Immunostimulator for enhancing the immune response induced by the antigen, containing as an active ingredient modified β-glucan, having immunostimulating effect, wherein β-glucan is covalently bound by biocompatible polyhydroxy acid. Medicinal agent for treating and/or preventing cancer. Vaccine for treating and/or preventing cancer (embodiments). Method for immunostimulation.
EFFECT: above immunostimulator speeds up the immune response.
12 cl, 22 dwg, 13 tbl, 17 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF 1,3-β-GLUCANES QUANTITATIVE DETERMINATION | 1991 |
|
RU2017819C1 |
| IMMUNOGENIC COMPOSITION | 2011 |
|
RU2593789C2 |
| FUNGAL STRAIN AUREOBASIDIUM PULLULANS PRODUCING EXOPOLYSACCHARIDE | 1989 |
|
SU1559718A1 |
| FUNGAL STRAIN AUREBASIDIUM PULLULANS PRODUCING EXOPOLYSACCHARIDE | 1988 |
|
SU1559717A1 |
| GLUCAN CONTAINING COMPOSITIONS | 2011 |
|
RU2596496C2 |
| COMPLEX CONTAINING AN OLIGONUCLEOTIDE, HAVING IMMUNOSTIMULATING ACTIVITY, AND ITS APPLICATION | 2014 |
|
RU2723943C2 |
| FERMENTATION PROCESS OF ASCOMYCETES | 2019 |
|
RU2754114C1 |
| ENZYME WITH ACTIVITY OF ENDO-1,3(4)-β-GLUCANASE, DNA ENCODING ITS AND METHOD FOR ITS PREPARING | 1995 |
|
RU2215034C2 |
| METHOD TO PREVENT CAVIAR AND YOUNG FISH DISEASES AFFECTED BY SAPROLEGNIA | 1995 |
|
RU2081575C1 |
| MOLECULE CONTAINING spr0096 AND spr2021 | 2012 |
|
RU2636350C2 |
